Current and emerging treatment options for prostate and bladder cancers were discussed at the second annual Interactive Genitourinary Cancer Conference (IGUCC) held in February 2010. The objectives of IGUCC‐2 were to provide physicians with practical clinical guidance concerning genitourinary cancers, discuss future treatment options, and encourage improved patient management and outcomes through closer multidisciplinary collaboration across the treatment continuum.